Significant correlation of serum IL-22 levels with CCL17 levels in atopic dermatitis

Journal of Dermatological Science

Volumn 61, Issue 1, 2011, Pages 78-79

  Hayashida, Sayaka ^a   Uchi, Hiroshi ^a   Takeuchi, Satoshi ^a   Esaki, Hitokazu ^a   Moroi, Yoichi ^a   Furue, Masutaka ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Atopic dermatitis; CCL17; CCL20; CCL27; ELISA; IL 22

Indexed keywords

INTERLEUKIN 22; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ADULT; ATOPIC DERMATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; IMMUNOREGULATION; LETTER; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

ADULT; CHEMOKINE CCL17; CHEMOKINE CCL20; CHEMOKINE CCL27; DERMATITIS, ATOPIC; HUMANS; INTERLEUKINS; YOUNG ADULT;

EID: 78650677427     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2010.08.013     Document Type: Letter

References (10)

1. Nakayama T., Fujisawa R., Yamada H., Horikawa T., Kawasaki H., Hieshima K., et al. Inducible expression of a CC chemokine liver- and activation-regulated chemokine (LARC)/macrophage inflammatory protein (MIP)-3 alpha/CCL20 by epidermal keratinocytes and its role in atopic dermatitis. Int Immunol 2001, 13(1):95-103.
2. Hijnen D., De Bruin-Weller M., Oosting B., Lebre C., De Jong E., Bruijnzeel-Koomen C., et al. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell-attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis. J Allergy Clin Immunol 2004, 113(2):334-340.
3. Wolk K., Witte E., Wallace E., Docke W.D., Kunz S., Asadullah K., et al. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur J Immunol 2006, 36(5):1309-1323.
4. Duhen T., Geiger R., Jarrossay D., Lanzavecchia A., Sallusto F. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol 2009, 10(8):857-863.
5. Nograles K.E., Zaba L.C., Shemer A., Fuentes-Duculan J., Cardinale I., Kikuchi T., et al. IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. J Allergy Clin Immunol 2009, 123(6). 1244-52 e2.
6. Saeki H., Furue M., Furukawa F., Hide M., Ohtsuki M., Katayama I., et al. Guidelines for management of atopic dermatitis. J Dermatol 2009, 36(10):563-577.
7. Ricciardi L., Minciullo P.L., Saitta S., Trombetta D., Saija A., Gangemi S. Increased serum levels of IL-22 in patients with nickel contact dermatitis. Contact Dermatitis 2009, 60(1):57-58.
8. Gangemi S., Minciullo P.L., Guarneri F., Cristani M., Arcoraci T., Spatari G., et al. Increased serum levels of interleukin-22 in patients affected by pityriasis rosea. J Eur Acad Dermatol Venereol 2009, 23(7):858-859.
9. Harper E.G., Guo C., Rizzo H., Lillis J.V., Kurtz S.E., Skorcheva I., et al. Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis. J Invest Dermatol 2009, 129(9):2175-2183.
10. Kim B.E., Leung D.Y., Streib J.E., Boguniewicz M., Hamid Q.A., Howell M.D. Macrophage inflammatory protein 3alpha deficiency in atopic dermatitis skin and role in innate immune response to vaccinia virus. J Allergy Clin Immunol 2007, 119(2):457-463.